Abstract
Despite significant advancements in managing acute ST-segment elevation myocardial infarctions, the prevalence of heart failure has not decreased. Emerging paradigms with a focus on reducing infarct size show promising evidence in the improvement of the incidence of heart failure after experiencing acute coronary syndromes. Limiting infarct size has been the focus of multiple clinical trials over the past decades and has led to left ventricular (LV) unloading as a potential mechanism. Contemporary use of microaxial flow devices for LV unloading has suggested improvement in mortality in acute myocardial infarction complicated by cardiogenic shock. This review focuses on clinical data demonstrating evidence of infarct size reduction and highlights ongoing clinical trials that provide a new therapeutic approach to the management of acute myocardial infarction.
| Original language | English |
|---|---|
| Pages (from-to) | 54-63 |
| Number of pages | 10 |
| Journal | Methodist DeBakey cardiovascular journal |
| Volume | 20 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2024 |
ASJC Scopus subject areas
- General Medicine
Keywords
- Impella
- cardiogenic shock
- hemodynamics
- mechanical circulatory support
- myocardial infarction
- reperfusion injury